Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
756525-98-1
1858264-36-4
2055040-99-6
2100306-52-1
2110449-02-8
2100306-51-0
16504-19-1 | N,N'-(Benzene-1,4-diyl)dibenzenesulphonamide | AA001V53 | MFCD00183146
160968-99-0 | 2-(2,2,2-Trifluoroethoxy)phenol | AA001VGT | MFCD11181824
161742-67-2 | 2,5-Dioxopyrrolidin-1-yl 2-methoxyacetate | AA001VRT | MFCD22193834
16538-67-3 | Silane, dichlorobis[(trichlorosilyl)methyl]- | AA001W1P
16588-15-1 | 2-Chloro-5-nitrobenzamide | AA001WB4 | MFCD00088420
166330-10-5 | Bis(2-diphenylphosphinophenyl)ether | AA001WKV | MFCD00233863
166747-91-7 | 2-(3-Formyl-1H-indol-1-yl)propanoic acid | AA001WU9 | MFCD03167983
16722-09-1 | trimethyl(oxiran-2-yl)silane | AA001X4I | MFCD31629132
16754-79-3 | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)tetrahydrofuran-3,4-diyl diacetate | AA001XDM | MFCD00192275
1680-36-0 | Nonanoic anhydride | AA001XNP | MFCD00057768